BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 895 filers reported holding BAXTER INTL INC in Q1 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $774,000 | -1.5% | 12,792 | -15.6% | 0.01% | -7.1% |
| Q1 2017 | $786,000 | -11.4% | 15,154 | -24.2% | 0.01% | -17.6% |
| Q4 2016 | $887,000 | +18.6% | 20,000 | +27.2% | 0.02% | +21.4% |
| Q3 2016 | $748,000 | -0.1% | 15,724 | -5.1% | 0.01% | -6.7% |
| Q2 2016 | $749,000 | +7.3% | 16,567 | -2.5% | 0.02% | +7.1% |
| Q1 2016 | $698,000 | +4.3% | 16,989 | -3.1% | 0.01% | +7.7% |
| Q4 2015 | $669,000 | -17.0% | 17,524 | -28.6% | 0.01% | -18.8% |
| Q3 2015 | $806,000 | -71.5% | 24,549 | -39.4% | 0.02% | -68.6% |
| Q2 2015 | $2,832,000 | +2.2% | 40,503 | +0.2% | 0.05% | +2.0% |
| Q1 2015 | $2,770,000 | -9.1% | 40,438 | -2.8% | 0.05% | -12.3% |
| Q4 2014 | $3,048,000 | +3.3% | 41,585 | +1.1% | 0.06% | +1.8% |
| Q3 2014 | $2,952,000 | -1.3% | 41,132 | -0.6% | 0.06% | +3.7% |
| Q2 2014 | $2,992,000 | +1.7% | 41,390 | +3.5% | 0.05% | 0.0% |
| Q1 2014 | $2,943,000 | +253.7% | 39,995 | +234.3% | 0.05% | +260.0% |
| Q4 2013 | $832,000 | -97.2% | 11,964 | -97.4% | 0.02% | -97.6% |
| Q3 2013 | $29,779,000 | -6.7% | 453,331 | -1.6% | 0.62% | -16.8% |
| Q2 2013 | $31,910,000 | – | 460,661 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |